Cardiovascular effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists or liraglutide in the EMPRISE study
Diabetologie Und Stoffwechsel(2023)
Abstract
Question How does the cardiovascular effectiveness of empagliflozin compare to the one from glucagon-like peptide-1 receptor agonists or liraglutide in a real-world US population?
MoreTranslated text
Key words
cardiovascular effectiveness,liraglutide,glucagon-like
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined